Nanomaterials for cancer therapy: current progress and perspectives

Z Cheng, M Li, R Dey, Y Chen - Journal of hematology & oncology, 2021 - Springer
Cancer is a disease with complex pathological process. Current chemotherapy faces
problems such as lack of specificity, cytotoxicity, induction of multi-drug resistance and stem …

Elucidating role of reactive oxygen species (ROS) in cisplatin chemotherapy: a focus on molecular pathways and possible therapeutic strategies

S Mirzaei, K Hushmandi, A Zabolian, H Saleki… - Molecules, 2021 - mdpi.com
The failure of chemotherapy is a major challenge nowadays, and in order to ensure effective
treatment of cancer patients, it is of great importance to reveal the molecular pathways and …

5 Carbon Nanomaterials

A Rasyotra, A Thakur, B Gaykwad… - … of Nanomaterials in …, 2024 - books.google.com
Carbon is the 15th most abundant element in the earth's crest and the 4th most abundant
element in the universe. It is the key component of deoxyribonucleic acid (DNA) and serves …

Carbon Nanomaterials: Novel Structures for Biological Applications

A Rasyotra, A Thakur, B Gaykwad, V Jani, K Jasuja - Nanobiotechnology - taylorfrancis.com
Carbon nanomaterials (CNs) have received tremendous interest in nanotechnology due to
their unique properties and flexible dimensional structure. The study of carbon-based …

[PDF][PDF] РОЗРОБКА ТЕХНОЛОГІЇ ПОСИЛЕННЯ ПРОТИПУХЛИННОЇ АКТИВНОСТІ ЦИСПЛАТИНУ ЗА ВИКОРИСТАННЯ С60 ФУЛЕРЕНУ

СВ ПРИЛУЦЬКА - biochemistry.org.ua
3 фулерену (0, 15 мг/мл, 2× 10-4 М), нормальні клітини (тимоцити та еритроцити щура),
клітини лейкемії ліній L1210 і CCRF-CEM, клітини карциноми легені LLC, модель …